News

News

JOINT STATEMENT BY THE NATIONAL INSURANCE BOARD AND THE BAHAMAS PHARMACEUTICAL ASSOCIATION

5/12/2010 4:49:00 AM
The National Insurance Board and The Bahamas Pharmaceutical Association announced on Thursday that they are working together to successfully launch the National Prescription Drug Plan (NPDP) in August of this year.

Both organizations said their single focus is to support the implementation of the plan which will ensure increased access to prescription medication for the treatment of eleven chronic diseases in Phase I of NPDP. In view of this resolve and the desire of both parties to contribute to instituting the Plan in its best possible form, NIB and the BPA have agreed that neither party will make any additional public statements regarding their discussions towards this goal.

Algernon Cargill, Director of NIB said “We do understand that there may be differences between NIB’s proposal and what the BPA and its members may want to see. NIB is working within a set of approved parameters that we believe provides for a fair and reasonable return, given all of the circumstances, to maximize the participation of local pharmacies. We have consulted widely with the BPA and other key stakeholders to ensure that the approved Plan will provide significant relief to Bahamians suffering from one or more of the 11 chronic diseases identified by NIB in the first phase of the Plan. The feedback we have received from registered beneficiaries and the general public is that NPDP is revolutionary and will increase their access to prescription medication and enable them to better manage their chronic conditions. We believe that at the end of the day, the NPDP that is being introduced will be successful and will be a wonderful business opportunity for the participating pharmacies that choose to join the Plan.”

Dr. Marvin Smith, President of the BPA said the intent of the BPA has always been to partner with the government to ensure a viable, sustainable plan for the Bahamian people.

“Pharmacists are a key part of the healthcare system and the BPA assures the public that our members view the access to healthcare as a fundamental right of every Bahamian. It is the intention of the BPA to continue to work with NIB to produce a programme that will benefit everyone it serves. We will do all we can to ensure that the Drug Plan and the private pharmacy sector can both be sustained, and that this Plan can provide benefit to our people for generations to come. We do this in the spirit of cooperation,” Dr. Smith said.
Comments (0) Add Comment Add Comment
Name

Comment
Captcha
Enter the code from the picture
NIB’s ELECTRONIC SERVICES TO SAFELY SERVE CUSTOMERS
All NIB Offices are operational. However, all face to face services have been suspended, with the exception of cheque payments and persons collecting cheques.
COVID-19 Connect With Us
COVID-19 Connect With Us
3/22/2020 12:09:37 PM
COVID-19 Connect with us, our staff stands ready to assist.
NIB COVID-19 Awareness Training
NIB COVID-19 Awareness Training
3/22/2020 7:19:07 AM
NIB Coronavirus Awareness Training- This video was produced to lend to the health and safety training towards "flattening the curve" of the Coronavirus spread. It is our hope that this provides NIBBERS easy and clear steps to follow within the NIB organization and within your family surroundings.
Government Funded Unemployment Assistance
On Thursday March 26, NIB will begin accepting applications for the Government-Funded Unemployment Assistance which will be extended to self employed persons...
NIB ACTIVATES ORANGE ALERT STAGE IN COVID-19 BUSINESS CONTINUITY PLAN
The National Insurance Board (NIB) has activated its Business Continuity Plan (BCP) to address potential business disruptions, which may come as a result of COVID-19. NIB has been in contact with the National Coordinating Committee to ensure that the necessary actions are consistent with the national response.
National Insurance and Coronavirus/COVID-19
How National Insurance provides for workers when income is suspended due to the Coronavirus/COVID-19 pandemic